Info

Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

[21] Rivera J, Garcia-Monforte A. Human immunodeficiency virus infection and arthritis. J Rheumatol 2000;27:1322-3.

[22] Carreüo Perez L. Septic arthritis. Baillieres Best Pract Res Clin Rheumatol 1999;13:37-58.

[23] Brantus JF, Meunier PJ. Rheumatic manifestations associated with human immunodeficiency virus infection. Rev Rhum Mal Osteoartic 1992;59:428-35.

[24] Njobvu P, McGill P, Kerr H, et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998;25:1553-9.

[25] Njobvu P, McGill P. Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol 2005;32:1299-304.

[26] Adebajo A, Davis P. Rheumatic diseases in African blacks. Semin Arthritis Rheum 1994; 24:139-53.

[27] Cuellar ML, Espinoza LR. Human immunodeficiency virus associated spondyloarthrop-athy: lessons from the Third World. J Rheumatol 1999;26:2071-3.

[28] Chinniah K, Mody GM, Bhimma R, et al. Arthritis in association with human immunodeficiency virus infection in black African children: causal or coincidental? Rheumatology (Oxford) 2005;44:915-20.

[29] Keat A, Rowe I. Reiter's syndrome and associated arthritides. Rheum Dis Clin North Am 1991;17:25-42.

[30] Saveuse H, Rouveix E, de Bandt M, et al. HLA-B27 inflammatory spondyloarthropathy, psoriasis and HIV infection. Presse Med 1988;17:698-9.

[31] De Bandt M, Saveuse H, Rouveix E, et al. Joint manifestations and HIV infections. Ann Med Interne (Paris) 1988;139:516-22.

[32] McGonagle D, Reade S, Marzo-Ortega H, et al. Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Ann Rheum Dis 2001;60:696-8.

[33] Forster SM, Seifert MH, Keat AC, et al. Inflammatory joint disease and human immunodeficiency virus infection. BMJ 1988;296:1625-7.

[34] Altman EM, Centeno LV, Mahal M, et al. AIDS-associated Reiter's syndrome. Ann Allergy 1994;72:307-16.

[35] Calabrese LH, O'Connell M, Kelley DM, et al. A longitudinal study of patients infected with the human immunodeficiency virus (HIV). The influence of rheumatic symptoms on the natural history of retroviral infections. Arthritis Rheum 1991;34:257-63.

[36] Iwakura Y, Tosu M, Yoshida E, et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 1991;253:1026-8.

[37] Medina F, Jara LJ, Miranda JM, et al. Successful outcome in HIV+ patients with Reiter's syndrome treated with bromocriptine. Arthritis Rheum 1993;36:727-8.

[38] Buskila D, Langevitz P, Tenenbaum J, et al. Malar rash in a patient with Reiter's syndrome: a clue for the diagnosis of human immunodeficiency virus infection. J Rheumatol 1990;17: 843-5.

[39] Blanche P. Acitretin and AIDS-related Reiter's disease. Clin Exp Rheumatol 1999;17: 105-6.

[40] Lassoued S, Lassoued K, Marchou B, et al. Course of ankylosing spondylitis (AS) in patients with human immunodeficiency virus (HIV). J Rheumatol 1991;18:1939-40.

[41] Mijiyawa M. Spondyloarthropathies in patients attending the rheumatology unit of Lome Hospital. J Rheumatol 1993;20:1167-9.

[42] Mijiyawa M, Oniankitan O, Kolani B, et al. Low back pain in hospital outpatients in Lome (Togo). Joint Bone Spine 2000;67:533-8.

[43] Mijiyawa M, Grunitzky K, Agbanouvi EA, et al. Spondylarthritis in Togolese patients. Ann Med Interne (Paris) 1991;142:582-6.

[44] Sipsas NV, Panayiotakopoulos GD, Zormpala A, et al. HIV infection and ankylosing spondylitis. Which benefits from the coexistence? Clin Rheumatol 2000;19:512.

[45] Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.

[46] Espinoza LR, Berman A, Vasey FB, et al. Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 1988;31:1034-40.

[47] Arnett FC, Reveille JD, Duvic M. Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am 1991;17:59-78.

[48] Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 2000;27:1699-702.

[49] Schewe CK, Kellner H. Rapidly progressive seronegative spondylarthropathy with atlan-todental subluxation in a patient with moderately advanced HIV infection. Clin Exp Rheumatol 1996;14:83-5.

[50] Pascual JS, Balos LL, Baer AN. Disseminated Prototheca wickerhamii infection with arthritis and tenosynovitis. J Rheumatol 2004;31:1861-5.

[51] Belzunegui J, Rodriguez-Arrondo F, Gonzalez C, et al. Musculoskeletal infections in intravenous drug addicts: report of 34 cases with analysis of microbiological aspects and pathogenic mechanisms. Clin Exp Rheumatol 2000;18:383-6.

[52] Monteagudo I, Rivera J, Lopez-Longo J, et al. AIDS and rheumatic manifestations in patients addicted to drugs: an analysis of 106 cases. J Rheumatol 1991;18:1038-41.

[53] Medina F, Hermida C, Jara LJ, et al. Staphylococcal arthritis in human immunodeficiency virus infection. Br J Rheumatol 1995;34:397-8.

[54] Barzilai A, Varon D, Martinowitz U, et al. Characteristics of septic arthritis in human immunodeficiency virus-infected haemophiliacs versus other risk groups. Rheumatology 1999;38:139-42.

[55] Tanaka S, Hachisuka K, Okazaki T, et al. Health status and satisfaction of asymptomatic HIV-positive haemophiliacs in Kyushu, Japan. Haemophilia 1999;5:56-62.

[56] Muüoz-Fernandez S, Cardenal A, Balsa A, et al. Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Semin Arthritis Rheum 1991;21:30-9.

[57] Medina F, Jara LJ, Miranda JM, et al. Artritis septica: reporte de 65 casos. Rev Mex Rheumatol 1995;10:175-9.

[58] Casado E, Olive A, Holgado S, et al. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count. J Rheumatol 2001;28: 802-4.

[59] Abouzahir A, Bouchama R, Azennag M, et al. Tropical pyomyositis simulating septic arthritis in AIDS patients. Two cases. Med Trop (Mars) 2004;64:372-4.

[60] Espinoza LR, Berman A. Soft tissues and osteo-articular infections in HIV-infected patients and other immunodeficient states. Baillieres Best Pract Res Clin Rheumatol 1999; 13:115-28.

[61] Medina F, Fuentes M, Jara LJ, et al. Salmonella pyomyositis in patients with the human immunodeficiency virus. Br J Rheumatol 1995;34:568-71.

[62] Reginato AJ. Syphilitic arthritis and osteitis. Rheum Dis Clin North Am 1993;19:379-98.

[63] Solomon G, Brancato L, Winchester R. An approach to the human immunodeficiency virus-positive patient with a spondyloarthropathic disease. Rheum Dis Clin North Am 1991;17:43-58.

[64] Chowdhry IA, Tan IJ, Mian N, et al. Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection. J Rheumatol 2005;32:1365-8.

[65] Massabki PS, Accetturi C, Nishie IA, et al. Clinical implications of autoantibodies in HIV infection. AIDS 1997;11:1845-50.

[66] Daikh BE, Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum 2001;30:418-25.

[67] McNeil HP, Chesterman CN, Krillis SA. Immunology and clinical importance of antiphos-pholipids antibodies. Adv Immunol 1991;49:193-280.

[68] Rubbert A, Bock E, Schwab J, et al. Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin Exp Immunol 1994;98:361-8.

[69] Authier FJ, Gherardi RK. Muscular complications of human immunodeficiency virus (HIV) infection in the era of effective anti-retroviral therapy. Rev Neurol (Paris) 2006; 162:71-81.

[70] Calabrese LH, Naides SJ. Viral arthritis. Infect Dis Clin North Am 2005;19:963-80.

[71] Reinhardt RL, Kang SJ, Liang HE, et al. T helper cell effector fates - who, how and where? Curr Opin Immunol 2006;18:271-7.

[72] Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-41.

[73] Seroude V, Audoly G, Gluschankof P, et al. Viral and cellular specificities of caprine arthritis encephalitis virus Vif protein. Virology 2002;292:156-61.

[74] Petkovic M, Metlas R. Cross-reactivity of the V3-speciflc antibodies with the human C1q. Z Naturforsch [C] 2001;56:1135-43.

[75] Bruhl H, Cihak J, Stangassinger M, et al. Depletion of CCR5-expressing cells with bispe-cific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV. J Immunol 2001;166:2420-6.

[76] Zapico I, Coto E, Rodriguez A, et al. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000;1:288-9.

[77] ShiehB, Liau YE, HsiehPS, etal. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol 2000;12:1311-8.

[78] Itescu S. Diffuse infiltrative lymphocytosis syndrome in children and adults infected with HIV-1: a model of rheumatic illness caused by acquired viral infection. Am J Reprod Immunol 1992;28:247-50.

[79] Hansen A, Feist E, Hiepe F, et al. Diffuse infiltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1. Arthritis Rheum 1999; 42:578-80.

[80] Weyand CM, Goronzy JJ. HIV infection and rheumatic diseases: autoimmune mechanisms in immunodeficient hosts. Z Rheumatol 1992;51:55-64.

[81] Fierabracci A, Upton CP, Hajibagheri N, et al. Lack of detection of retroviral particles (HIAP-1) in the H9 T cell line co-cultured with thyrocytes of Graves' disease. J Autoimmun 2001;16:457-62.

[82] Sander DM, Szabo S, Gallaher WR. Involvement of human intracisternal A-type retroviral particles in autoimmunity. Microsc Res Tech 2005;68:222-34.

[83] Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 2001;16:275-85.

[84] Stellbrink HJ, van Lunzen J. Lymph node during antiretroviral treatment. Curr Opin Infect Dis 2001;14:17-22.

[85] Carr A, Samaras K, Burton S, et al. A syndrome ofperipheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV-protease inhibitors. AIDS 1998;12:F51-8.

[86] Behrens G, Schmidt H, Meyer D, et al. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998;351:1958.

[87] Brooks JI, Gallicano K, Garber G, et al. Acute monoarthritis complicating therapy with indinavir. AIDS 2000;14:2064-5.

[88] Allroggen A, Frese A, Rahmann A, et al. HIV associated arthritis: case report and review of the literature. Eur J Med Res 2005;10:305-8.

[89] Florence E, Schrooten W, Verdont K, et al. Rheumatological complication associated with the use of indinavir and other protease inhibitors. Ann Rheum Dis 2002;61:82-4.

[90] Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000;30:147-66.

[91] Paton NIJ, Macallan DC, Griffin GE, et al. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997;61:30-2.

[92] Tebas P, Powderly WG, Claxton S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000;10:F63-7.

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook


Post a comment